|
Market Closed -
OTC Markets
22:51:35 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0225 USD | -2.17% |
|
-0.66% | -13.46% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.96M | - | - | - | - | - |
| 78.35B | |||||
| 61.52B | - | ||||
| 59.78B | |||||
| 46.53B | |||||
| 45.5B |
Select your edition
All financial news and data tailored to specific country editions
